サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1715286

セマグルチド中間体P29の世界市場、実績と予測（2020年～2031年）

Global Semaglutide Intermediate P29 Market Report, History and Forecast 2020-2031

出版日
発行
QYResearch
ページ情報
英文 118 Pages
納期
2～3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
セマグルチド中間体P29の世界市場、実績と予測（2020年～2031年）
出版日: 2025年04月30日
発行: QYResearch
ページ情報: 英文 118 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のセマグルチド中間体P29の市場規模は、2024年に8,342万米ドルであり、2031年までに14億5,176万米ドルに達すると予測され、2025年～2031年の予測期間にCAGRで50.60%の成長が見込まれます。

北米の市場規模は、2024年に1,902万米ドルであり、2031年までに2億8,348万米ドルに達すると予測され、2024年～2031年の予測期間のCAGRは48.30%です。

アジア太平洋の市場規模は、2024年に4,147万米ドルであり、2031年までに8億36万米ドルに達すると予測され、2024年～2031年の予測期間のCAGRは52.10%です。

欧州の市場規模は、2024年に2,165万米ドルであり、2031年までに3億4,890万米ドルに達すると予測され、2024年～2031年の予測期間のCAGRは49.44%です。

当レポートでは、世界のセマグルチド中間体P29市場について調査分析し、各地域の市場規模と予測、競合情勢、主要企業のプロファイル、技術動向、新製品開発などの情報を提供しています。

目次

第1章 セマグルチド中間体P29市場の概要

  • セマグルチド中間体P29製品の概要
  • セマグルチド中間体P29市場：タイプ別
    • 99%以上
    • その他
  • 世界のセマグルチド中間体P29の市場規模：タイプ別
    • 世界のセマグルチド中間体P29の市場規模の概要：タイプ別（2020年～2031年）
    • 世界のセマグルチド中間体P29の市場規模の実績：タイプ別（2020年～2025年）
    • 世界のセマグルチド中間体P29の市場規模の予測：タイプ別（2026年～2031年）
  • 市場規模：主要地域別
    • 北米のセマグルチド中間体P29の売上の内訳：タイプ別（2020年～2025年）
    • 欧州のセマグルチド中間体P29の売上の内訳：タイプ別（2020年～2025年）
    • アジア太平洋のセマグルチド中間体P29の売上の内訳：タイプ別（2020年～2025年）
    • ラテンアメリカのセマグルチド中間体P29の売上の内訳：タイプ別（2020年～2025年）
    • 中東・アフリカのセマグルチド中間体P29の売上の内訳：タイプ別（2020年～2025年）

第2章 セマグルチド中間体P29市場の各社の競合

  • 世界の主要企業：セマグルチド中間体P29の売上別（2020年～2025年）
  • 世界の主要企業：セマグルチド中間体P29の収益別（2020年～2025年）
  • 世界の主要企業：セマグルチド中間体P29の価格別（2020年～2025年）
  • 世界の主要メーカーのセマグルチド中間体P29製造拠点の分布と本社
  • セマグルチド中間体P29市場の競合情勢と動向
    • セマグルチド中間体P29の市場集中度（2020年～2025年）
    • 世界のセマグルチド中間体P29の収益における3大・5大メーカー（2024年）
  • 世界の主要メーカー：企業タイプ別（Tier 1・Tier 2・Tier 3）（2024年時点のセマグルチド中間体P29の収益に基づく）
  • 主要メーカーのセマグルチド中間体P29製品

第3章 セマグルチド中間体P29の現状と見通し：地域別

  • 世界のセマグルチド中間体P29の市場規模とCAGR：地域別（2020年・2024年・2031年）
  • 世界のセマグルチド中間体P29の市場規模の実績：地域別
    • 世界のセマグルチド中間体P29の売上数量：地域別（2020年～2025年）
    • 世界のセマグルチド中間体P29の売上金額：地域別（2020年～2025年）
    • 世界のセマグルチド中間体P29の売上（数量と金額）、価格、粗利益（2020年～2025年）
  • 世界のセマグルチド中間体P29の市場規模の予測：地域別
    • 世界のセマグルチド中間体P29の売上数量：地域別（2026年～2031年）
    • 世界のセマグルチド中間体P29の売上金額：地域別（2026年～2031年）
    • 世界のセマグルチド中間体P29の売上（数量と金額）、価格、粗利益（2026年～2031年）

第4章 セマグルチド中間体P29：用途別

  • セマグルチド中間体P29市場：用途別
    • 経口
    • 注射
  • 世界のセマグルチド中間体P29の市場規模：用途別
    • 世界のセマグルチド中間体P29の市場規模の概要：用途別（2020年～2031年）
    • 世界のセマグルチド中間体P29の市場規模の実績：用途別（2020年～2025年）
    • 世界のセマグルチド中間体P29の市場規模の予測：用途別（2026年～2031年）
  • 主要地域の市場規模：用途別
    • 北米のセマグルチド中間体P29の売上の内訳：用途別（2020年～2025年）
    • 欧州のセマグルチド中間体P29の売上の内訳：用途別（2020年～2025年）
    • アジア太平洋のセマグルチド中間体P29の売上の内訳：用途別（2020年～2025年）
    • ラテンアメリカのセマグルチド中間体P29の売上の内訳：用途別（2020年～2025年）
    • 中東・アフリカのセマグルチド中間体P29の売上の内訳：用途別（2020年～2025年）

第5章 北米のセマグルチド中間体P29：国別

  • 北米のセマグルチド中間体P29の市場規模の実績：国別
  • 北米のセマグルチド中間体P29の市場規模の予測：国別

第6章 欧州のセマグルチド中間体P29：国別

  • 欧州のセマグルチド中間体P29の市場規模の実績：国別
  • 欧州のセマグルチド中間体P29の市場規模の予測：国別

第7章 アジア太平洋のセマグルチド中間体P29：地域別

  • アジア太平洋のセマグルチド中間体P29の市場規模の実績：地域別
  • アジア太平洋のセマグルチド中間体P29の市場規模の予測：地域別

第8章 企業プロファイル

  • Zhuhai Gene-Biocon Biological Technology Co., Ltd.
  • Vazyme International LLC
  • PEG-BIO Biopharm Co
  • Asymchem Inc.
  • Nanjing Hanxin Pharmaceutical Technology Co., Ltd.
  • Nanjing Abydos Pharma Co., Ltd.
  • Changzhou Xuanming Pharmaceutical Technology Co., Ltd.

第9章 上流、機会、課題、リスク、影響要因の分析

  • セマグルチド中間体P29の主な原材料
    • 主な原材料
    • 原材料の主要サプライヤー
  • 製造コスト構造
    • 原材料
    • 人件費
    • 製造費
  • セマグルチド中間体P29の生産プロセス
  • セマグルチド中間体P29の市場力学
    • セマグルチド中間体P29産業の動向
    • セマグルチド中間体P29市場の促進要因
    • セマグルチド中間体P29市場の課題
    • セマグルチド中間体P29市場の抑制要因

第10章 セマグルチド中間体P29の下流顧客

第11章 調査結果と結論

第12章 付録

図表

List of Tables

  • Table 1. Major Company of >= 99%
  • Table 2. Major Company of Others
  • Table 3. Global Semaglutide Intermediate P29 Sales by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 4. Global Semaglutide Intermediate P29 Sales by Type (2020-2025) & (Kg)
  • Table 5. Global Semaglutide Intermediate P29 Sales Market Share in Volume by Type (2020-2025)
  • Table 6. Global Semaglutide Intermediate P29 Sales by Type (2020-2025) & (US$ Million)
  • Table 7. Global Semaglutide Intermediate P29 Sales Market Share in Value by Type (2020-2025)
  • Table 8. Global Semaglutide Intermediate P29 Price by Type (2020-2025) & (US$/Kg)
  • Table 9. Global Semaglutide Intermediate P29 Sales by Type (2026-2031) & (Kg)
  • Table 10. Global Semaglutide Intermediate P29 Sales Market Share in Volume by Type (2026-2031)
  • Table 11. Global Semaglutide Intermediate P29 Sales by Type (2026-2031) & (US$ Million)
  • Table 12. Global Semaglutide Intermediate P29 Sales Market Share in Value by Type (2026-2031)
  • Table 13. Global Semaglutide Intermediate P29 Price by Type (2026-2031) & (US$/Kg)
  • Table 14. North America Semaglutide Intermediate P29 Sales by Type (2020-2025) & (Kg)
  • Table 15. North America Semaglutide Intermediate P29 Sales by Type (2020-2025) & (US$ Million)
  • Table 16. Europe Semaglutide Intermediate P29 Sales (Kg) by Type (2020-2025)
  • Table 17. Europe Semaglutide Intermediate P29 Sales by Type (2020-2025) & (US$ Million)
  • Table 18. Asia-Pacific Semaglutide Intermediate P29 Sales (Kg) by Type (2020-2025)
  • Table 19. Asia-Pacific Semaglutide Intermediate P29 Sales by Type (2020-2025) & (US$ Million)
  • Table 20. Latin America Semaglutide Intermediate P29 Sales (Kg) by Type (2020-2025)
  • Table 21. Latin America Semaglutide Intermediate P29 Sales by Type (2020-2025) & (US$ Million)
  • Table 22. Middle East and Africa Semaglutide Intermediate P29 Sales (Kg) by Type (2020-2025)
  • Table 23. Middle East and Africa Semaglutide Intermediate P29 Sales by Type (2020-2025) & (US$ Million)
  • Table 24. Global Semaglutide Intermediate P29 Sales by Company (2020-2025) & (Kg)
  • Table 25. Global Semaglutide Intermediate P29 Sales Share by Company (2020-2025)
  • Table 26. Global Semaglutide Intermediate P29 Revenue by Company (2020-2025) & (US$ Million)
  • Table 27. Global Semaglutide Intermediate P29 Revenue Share by Company (2020-2025)
  • Table 28. Global Market Semaglutide Intermediate P29 Price by Company (2020-2025) & (US$/Kg)
  • Table 29. Global Semaglutide Intermediate P29 Top Manufacturers Manufacturing Base Distribution and Headquarters
  • Table 30. Global Semaglutide Intermediate P29 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Semaglutide Intermediate P29 as of 2024)
  • Table 32. Key Manufacturers Semaglutide Intermediate P29 Product Type
  • Table 33. Global Semaglutide Intermediate P29 Market Size Comparison by Region (US$ Million): 2020 VS 2024 VS 2031
  • Table 34. Global Semaglutide Intermediate P29 Sales by Region (2020-2025) & (Kg)
  • Table 35. Global Semaglutide Intermediate P29 Sales Market Share in Volume by Region (2020-2025)
  • Table 36. Global Semaglutide Intermediate P29 Sales by Region (2020-2025) & (US$ Million)
  • Table 37. Global Semaglutide Intermediate P29 Sales Market Share in Value by Region (2020-2025)
  • Table 38. Global Semaglutide Intermediate P29 Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
  • Table 39. Global Semaglutide Intermediate P29 Sales by Region (2026-2031) & (Kg)
  • Table 40. Global Semaglutide Intermediate P29 Sales Market Share in Volume by Region (2026-2031)
  • Table 41. Global Semaglutide Intermediate P29 Sales by Region (2026-2031) & (US$ Million)
  • Table 42. Global Semaglutide Intermediate P29 Sales Market Share in Value by Region (2026-2031)
  • Table 43. Global Semaglutide Intermediate P29 Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2026-2031)
  • Table 44. Global Semaglutide Intermediate P29 Sales by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 45. Global Semaglutide Intermediate P29 Sales by Application (2020-2025) & (Kg)
  • Table 46. Global Semaglutide Intermediate P29 Sales Market Share in Volume by Application (2020-2025)
  • Table 47. Global Semaglutide Intermediate P29 Sales by Application (2020-2025) & (US$ Million)
  • Table 48. Global Semaglutide Intermediate P29 Sales Market Share in Value by Application (2020-2025)
  • Table 49. Global Semaglutide Intermediate P29 Price by Application (2020-2025) & (US$/Kg)
  • Table 50. Global Semaglutide Intermediate P29 Sales by Application (2026-2031) & (Kg)
  • Table 51. Global Semaglutide Intermediate P29 Sales Market Share in Volume by Application (2026-2031)
  • Table 52. Global Semaglutide Intermediate P29 Sales by Application (2026-2031) & (US$ Million)
  • Table 53. Global Semaglutide Intermediate P29 Sales Market Share in Value by Application (2026-2031)
  • Table 54. Global Semaglutide Intermediate P29 Price by Application (2026-2031) & (US$/Kg)
  • Table 55. North America Semaglutide Intermediate P29 Sales by Application (2020-2025) & (Kg)
  • Table 56. North America Semaglutide Intermediate P29 Sales by Application (2020-2025) & (US$ Million)
  • Table 57. Europe Semaglutide Intermediate P29 Sales (Kg) by Application (2020-2025)
  • Table 58. Europe Semaglutide Intermediate P29 Sales by Application (2020-2025) & (US$ Million)
  • Table 59. Asia-Pacific Semaglutide Intermediate P29 Sales (Kg) by Application (2020-2025)
  • Table 60. Asia-Pacific Semaglutide Intermediate P29 Sales by Application (2020-2025) & (US$ Million)
  • Table 61. Latin America Semaglutide Intermediate P29 Sales (Kg) by Application (2020-2025)
  • Table 62. Latin America Semaglutide Intermediate P29 Sales by Application (2020-2025) & (US$ Million)
  • Table 63. Middle East and Africa Semaglutide Intermediate P29 Sales (Kg) by Application (2020-2025)
  • Table 64. Middle East and Africa Semaglutide Intermediate P29 Sales by Application (2020-2025) & (US$ Million)
  • Table 65. North America Semaglutide Intermediate P29 Market Size Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
  • Table 66. North America Semaglutide Intermediate P29 Sales by Country (2020-2025) & (Kg)
  • Table 67. North America Semaglutide Intermediate P29 Sales Market Share in Volume by Country (2020-2025)
  • Table 68. North America Semaglutide Intermediate P29 Sales by Country (2020-2025) & (US$ Million)
  • Table 69. North America Semaglutide Intermediate P29 Sales Market Share in Value by Country (2020-2025)
  • Table 70. North America Semaglutide Intermediate P29 Sales by Country (2026-2031) & (Kg)
  • Table 71. North America Semaglutide Intermediate P29 Sales Market Share in Volume by Country (2026-2031)
  • Table 72. North America Semaglutide Intermediate P29 Sales by Country (2026-2031) & (US$ Million)
  • Table 73. North America Semaglutide Intermediate P29 Sales Market Share in Value by Country (2026-2031)
  • Table 74. Europe Semaglutide Intermediate P29 Market Size Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
  • Table 75. Europe Semaglutide Intermediate P29 Sales by Country (2020-2025) & (Kg)
  • Table 76. Europe Semaglutide Intermediate P29 Sales Market Share in Volume by Country (2020-2025)
  • Table 77. Europe Semaglutide Intermediate P29 Sales by Country (2020-2025) & (US$ Million)
  • Table 78. Europe Semaglutide Intermediate P29 Sales Market Share in Value by Country (2020-2025)
  • Table 79. Europe Semaglutide Intermediate P29 Sales by Country (2026-2031) & (Kg)
  • Table 80. Europe Semaglutide Intermediate P29 Sales Market Share in Volume by Country (2026-2031)
  • Table 81. Europe Semaglutide Intermediate P29 Sales by Country (2026-2031) & (US$ Million)
  • Table 82. Europe Semaglutide Intermediate P29 Sales Market Share in Value by Country (2026-2031)
  • Table 83. Asia-Pacific Semaglutide Intermediate P29 Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031
  • Table 84. Asia-Pacific Semaglutide Intermediate P29 Sales by Region (2020-2025) & (Kg)
  • Table 85. Asia-Pacific Semaglutide Intermediate P29 Sales Market Share in Volume by Region (2020-2025)
  • Table 86. Asia-Pacific Semaglutide Intermediate P29 Sales by Region (2020-2025) & (US$ Million)
  • Table 87. Asia-Pacific Semaglutide Intermediate P29 Sales Market Share in Value by Region (2020-2025)
  • Table 88. Asia-Pacific Semaglutide Intermediate P29 Sales by Region (2026-2031) & (Kg)
  • Table 89. Asia-Pacific Semaglutide Intermediate P29 Sales Market Share in Volume by Region (2026-2031)
  • Table 90. Asia-Pacific Semaglutide Intermediate P29 Sales by Region (2026-2031) & (US$ Million)
  • Table 91. Asia-Pacific Semaglutide Intermediate P29 Sales Market Share in Value by Region (2026-2031)
  • Table 92. Zhuhai Gene-Biocon Biological Technology Co., Ltd. Company Information
  • Table 93. Zhuhai Gene-Biocon Biological Technology Co., Ltd. Introduction and Business Overview
  • Table 94. Zhuhai Gene-Biocon Biological Technology Co., Ltd. Semaglutide Intermediate P29 Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
  • Table 95. Zhuhai Gene-Biocon Biological Technology Co., Ltd. Semaglutide Intermediate P29 Product
  • Table 96. Vazyme International LLC Company Information
  • Table 97. Vazyme International LLC Introduction and Business Overview
  • Table 98. Vazyme International LLC Semaglutide Intermediate P29 Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
  • Table 99. Vazyme International LLC Semaglutide Intermediate P29 Product
  • Table 100. PEG-BIO Biopharm Co Company Information
  • Table 101. PEG-BIO Biopharm Co Introduction and Business Overview
  • Table 102. PEG-BIO Biopharm Co Semaglutide Intermediate P29 Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
  • Table 103. PEG-BIO Biopharm Co Semaglutide Intermediate P29 Product
  • Table 104. PEG-BIO Biopharm Co Recent Development
  • Table 105. Asymchem Inc. Company Information
  • Table 106. Asymchem Inc. Introduction and Business Overview
  • Table 107. Asymchem Inc. Semaglutide Intermediate P29 Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
  • Table 108. Asymchem Inc. Semaglutide Intermediate P29 Product
  • Table 109. Nanjing Hanxin Pharmaceutical Technology Co.,Ltd. Company Information
  • Table 110. Nanjing Hanxin Pharmaceutical Technology Co.,Ltd. Introduction and Business Overview
  • Table 111. Nanjing Hanxin Pharmaceutical Technology Co.,Ltd. Semaglutide Intermediate P29 Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
  • Table 112. Nanjing Hanxin Pharmaceutical Technology Co.,Ltd. Semaglutide Intermediate P29 Product
  • Table 113. Nanjing Abydos Pharma Co.,Ltd. Company Information
  • Table 114. Nanjing Abydos Pharma Co.,Ltd. Introduction and Business Overview
  • Table 115. Nanjing Abydos Pharma Co.,Ltd. Semaglutide Intermediate P29 Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
  • Table 116. Nanjing Abydos Pharma Co.,Ltd. Semaglutide Intermediate P29 Product
  • Table 117. Changzhou Xuanming Pharmaceutical Technology Co., Ltd. Company Information
  • Table 118. Changzhou Xuanming Pharmaceutical Technology Co., Ltd. Introduction and Business Overview
  • Table 119. Changzhou Xuanming Pharmaceutical Technology Co., Ltd. Semaglutide Intermediate P29 Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
  • Table 120. Changzhou Xuanming Pharmaceutical Technology Co., Ltd. Semaglutide Intermediate P29 Product
  • Table 121. Key Raw Materials Lists
  • Table 122. Raw Materials Key Suppliers Lists
  • Table 123. Semaglutide Intermediate P29 Market Trends
  • Table 124. Semaglutide Intermediate P29 Market Drivers
  • Table 125. Semaglutide Intermediate P29 Market Challenges
  • Table 126. Semaglutide Intermediate P29 Market Restraints
  • Table 127. Semaglutide Intermediate P29 Downstream Customers
  • Table 128. Research Programs/Design for This Report
  • Table 129. Key Data Information from Secondary Sources
  • Table 130. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Semaglutide Intermediate P29 Product Picture
  • Figure 2. Global Semaglutide Intermediate P29 Market Size, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Semaglutide Intermediate P29 Market Size Status and Outlook (2020-2031) & (US$ Million)
  • Figure 4. Global Semaglutide Intermediate P29 Sales Status and Outlook (2020-2031) & (Kg)
  • Figure 5. Product Picture of >= 99%
  • Figure 6. Global >= 99% Sales YoY Growth (2020-2031) & (Kg)
  • Figure 7. Product Picture of 95%
  • Figure 8. Global Others Sales YoY Growth (2020-2031) & (Kg)
  • Figure 9. Global Semaglutide Intermediate P29 Sales by Type (2020-2031) & (US$ Million)
  • Figure 10. Global Semaglutide Intermediate P29 Market Share by Type in 2024 & 2031
  • Figure 11. North America Semaglutide Intermediate P29 Sales Market Share in Volume by Type in 2024
  • Figure 12. North America Semaglutide Intermediate P29 Sales Market Share in Value by Type in 2024
  • Figure 13. Europe Semaglutide Intermediate P29 Sales Market Share in Volume by Type in 2024
  • Figure 14. Europe Semaglutide Intermediate P29 Sales Market Share in Value by Type in 2024
  • Figure 15. Asia-Pacific Semaglutide Intermediate P29 Sales Market Share in Volume by Type in 2024
  • Figure 16. Asia-Pacific Semaglutide Intermediate P29 Sales Market Share in Value by Type in 2024
  • Figure 17. Latin America Semaglutide Intermediate P29 Sales Market Share in Volume by Type in 2024
  • Figure 18. Latin America Semaglutide Intermediate P29 Sales Market Share in Value by Type in 2024
  • Figure 19. Middle East and Africa Semaglutide Intermediate P29 Sales Market Share in Volume by Type in 2024
  • Figure 20. Middle East and Africa Semaglutide Intermediate P29 Sales Market Share in Value by Type in 2024
  • Figure 21. The 3 and 5 Largest Manufacturers in the World: Market Share by Semaglutide Intermediate P29 Revenue in 2024
  • Figure 22. Semaglutide Intermediate P29 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 23. Product Picture of Oral Preparations
  • Figure 24. Global Oral Preparations Sales YoY Growth (2020-2031) & (Kg)
  • Figure 25. Product Picture of Injections
  • Figure 26. Global Injections Sales YoY Growth (2020-2031) & (Kg)
  • Figure 27. Global Semaglutide Intermediate P29 Sales by Application (2020-2031) & (US$ Million)
  • Figure 28. Global Semaglutide Intermediate P29 Market Share by Application in 2024 & 2031
  • Figure 29. North America Semaglutide Intermediate P29 Sales Market Share in Volume by Application in 2024
  • Figure 30. North America Semaglutide Intermediate P29 Sales Market Share in Value by Application in 2024
  • Figure 31. Europe Semaglutide Intermediate P29 Sales Market Share in Volume by Application in 2024
  • Figure 32. Europe Semaglutide Intermediate P29 Sales Market Share in Value by Application in 2024
  • Figure 33. Asia-Pacific Semaglutide Intermediate P29 Sales Market Share in Volume by Application in 2024
  • Figure 34. Asia-Pacific Semaglutide Intermediate P29 Sales Market Share in Value by Application in 2024
  • Figure 35. Latin America Semaglutide Intermediate P29 Sales Market Share in Volume by Application in 2024
  • Figure 36. Latin America Semaglutide Intermediate P29 Sales Market Share in Value by Application in 2024
  • Figure 37. Middle East and Africa Semaglutide Intermediate P29 Sales Market Share in Volume by Application in 2024
  • Figure 38. Middle East and Africa Semaglutide Intermediate P29 Sales Market Share in Value by Application in 2024
  • Figure 39. Semaglutide Intermediate P29 Manufacturing Cost Structure
  • Figure 40. Semaglutide Intermediate P29 Production Process
  • Figure 41. Bottom-up and Top-down Approaches for This Report
  • Figure 42. Data Triangulation
  • Figure 43. Key Executives Interviewed
目次

The global market for Semaglutide Intermediate P29 was valued at US$ 83.42 million in the year 2024 and is projected to reach a revised size of US$ 1,451.76 million by 2031, growing at a CAGR of 50.60% during the forecast period 2025-2031.

North American market for Semaglutide Intermediate P29 was valued at $ 19.02 million in 2024 and will reach $ 283.48 million by 2031, at a CAGR of 48.30% during the forecast period of 2024 through 2031.

Asia-Pacific market for Semaglutide Intermediate P29 was valued at $ 41.47 million in 2024 and will reach $ 800.36 million by 2031, at a CAGR of 52.10% during the forecast period of 2024 through 2031.

Europe market for Semaglutide Intermediate P29 was valued at $ 21.65 million in 2024 and will reach $ 348.90 million by 2031, at a CAGR of 49.44% during the forecast period of 2024 through 2031.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Semaglutide Intermediate P29, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Semaglutide Intermediate P29.

The Semaglutide Intermediate P29 market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Semaglutide Intermediate P29 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Semaglutide Intermediate P29 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

Market Segmentation

This report covers the Semaglutide Intermediate P29 segments by manufacturers, by Type, by Application, by region and country, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2020-2024, 2025-2031), considering 2024 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

By Company

  • Zhuhai Gene-Biocon Biological Technology Co., Ltd.
  • Vazyme International LLC
  • PEG-BIO Biopharm Co,.(Chongqing)
  • Asymchem Inc.
  • Nanjing Hanxin Pharmaceutical Technology Co.,Ltd.
  • Nanjing Abydos Pharma Co.,Ltd.
  • Changzhou Xuanming Pharmaceutical Technology Co., Ltd.

Segment by Type

  • >= 99%
  • Others

Segment by Application

  • Oral Preparations
  • Injections

By Region

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Europe
  • Germany
  • France
  • Denmark
  • Switzerland
  • Italy
  • Latin America
  • Middle East & Africa

Chapter Outline

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Chapter Two: Detailed analysis of Semaglutide Intermediate P29 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter Three: Sales, revenue of Semaglutide Intermediate P29 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Chapter Five, Six, Seven: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.

Chapter Eigh: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter Nine: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter Ten: Analysis of customers.

Chapter Eleven: Research Findings and Conclusion.

Table of Contents

1 Semaglutide Intermediate P29 Market Overview

  • 1.1 Semaglutide Intermediate P29 Product Overview
  • 1.2 Semaglutide Intermediate P29 Market by Type
    • 1.2.1 >= 99%
    • 1.2.2 Others
  • 1.3 Global Semaglutide Intermediate P29 Market Size by Type
    • 1.3.1 Global Semaglutide Intermediate P29 Market Size Overview by Type (2020-2031)
    • 1.3.2 Global Semaglutide Intermediate P29 Historic Market Size Review by Type (2020-2025)
    • 1.3.3 Global Semaglutide Intermediate P29 Forecasted Market Size by Type (2026-2031)
  • 1.4 Key Regions Market Size by Type
    • 1.4.1 North America Semaglutide Intermediate P29 Sales Breakdown by Type (2020-2025)
    • 1.4.2 Europe Semaglutide Intermediate P29 Sales Breakdown by Type (2020-2025)
    • 1.4.3 Asia-Pacific Semaglutide Intermediate P29 Sales Breakdown by Type (2020-2025)
    • 1.4.4 Latin America Semaglutide Intermediate P29 Sales Breakdown by Type (2020-2025)
    • 1.4.5 Middle East and Africa Semaglutide Intermediate P29 Sales Breakdown by Type (2020-2025)

2 Semaglutide Intermediate P29 Market Competition by Company

  • 2.1 Global Top Players by Semaglutide Intermediate P29 Sales (2020-2025)
  • 2.2 Global Top Players by Semaglutide Intermediate P29 Revenue (2020-2025)
  • 2.3 Global Top Players by Semaglutide Intermediate P29 Price (2020-2025)
  • 2.4 Global Top Manufacturers Semaglutide Intermediate P29 Manufacturing Base Distribution and Headquarters
  • 2.5 Semaglutide Intermediate P29 Market Competitive Situation and Trends
    • 2.5.1 Semaglutide Intermediate P29 Market Concentration Rate (2020-2025)
    • 2.5.2 Global 3 and 5 Largest Manufacturers by Semaglutide Intermediate P29 Revenue in 2024
  • 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Semaglutide Intermediate P29 as of 2024)
  • 2.7 Key Manufacturers Semaglutide Intermediate P29 Product Offered

3 Semaglutide Intermediate P29 Status and Outlook by Region

  • 3.1 Global Semaglutide Intermediate P29 Market Size and CAGR by Region: 2020 VS 2024 VS 2031
  • 3.2 Global Semaglutide Intermediate P29 Historic Market Size by Region
    • 3.2.1 Global Semaglutide Intermediate P29 Sales in Volume by Region (2020-2025)
    • 3.2.2 Global Semaglutide Intermediate P29 Sales in Value by Region (2020-2025)
    • 3.2.3 Global Semaglutide Intermediate P29 Sales (Volume & Value), Price and Gross Margin (2020-2025)
  • 3.3 Global Semaglutide Intermediate P29 Forecasted Market Size by Region
    • 3.3.1 Global Semaglutide Intermediate P29 Sales in Volume by Region (2026-2031)
    • 3.3.2 Global Semaglutide Intermediate P29 Sales in Value by Region (2026-2031)
    • 3.3.3 Global Semaglutide Intermediate P29 Sales (Volume & Value), Price and Gross Margin (2026-2031)

4 Semaglutide Intermediate P29 by Application

  • 4.1 Semaglutide Intermediate P29 Market by Application
    • 4.1.1 Oral Preparations
    • 4.1.2 Injections
  • 4.2 Global Semaglutide Intermediate P29 Market Size by Application
    • 4.2.1 Global Semaglutide Intermediate P29 Market Size Overview by Application (2020-2031)
    • 4.2.2 Global Semaglutide Intermediate P29 Historic Market Size Review by Application (2020-2025)
    • 4.2.3 Global Semaglutide Intermediate P29 Forecasted Market Size by Application (2026-2031)
  • 4.3 Key Regions Market Size by Application
    • 4.3.1 North America Semaglutide Intermediate P29 Sales Breakdown by Application (2020-2025)
    • 4.3.2 Europe Semaglutide Intermediate P29 Sales Breakdown by Application (2020-2025)
    • 4.3.3 Asia-Pacific Semaglutide Intermediate P29 Sales Breakdown by Application (2020-2025)
    • 4.3.4 Latin America Semaglutide Intermediate P29 Sales Breakdown by Application (2020-2025)
    • 4.3.5 Middle East and Africa Semaglutide Intermediate P29 Sales Breakdown by Application (2020-2025)

5 North America Semaglutide Intermediate P29 by Country

  • 5.1 North America Semaglutide Intermediate P29 Historic Market Size by Country
    • 5.1.1 North America Semaglutide Intermediate P29 Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
    • 5.1.2 North America Semaglutide Intermediate P29 Sales in Volume by Country (2020-2025)
    • 5.1.3 North America Semaglutide Intermediate P29 Sales in Value by Country (2020-2025)
  • 5.2 North America Semaglutide Intermediate P29 Forecasted Market Size by Country
    • 5.2.1 North America Semaglutide Intermediate P29 Sales in Volume by Country (2026-2031)
    • 5.2.2 North America Semaglutide Intermediate P29 Sales in Value by Country (2026-2031)

6 Europe Semaglutide Intermediate P29 by Country

  • 6.1 Europe Semaglutide Intermediate P29 Historic Market Size by Country
    • 6.1.1 Europe Semaglutide Intermediate P29 Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
    • 6.1.2 Europe Semaglutide Intermediate P29 Sales in Volume by Country (2020-2025)
    • 6.1.3 Europe Semaglutide Intermediate P29 Sales in Value by Country (2020-2025)
  • 6.2 Europe Semaglutide Intermediate P29 Forecasted Market Size by Country
    • 6.2.1 Europe Semaglutide Intermediate P29 Sales in Volume by Country (2026-2031)
    • 6.2.2 Europe Semaglutide Intermediate P29 Sales in Value by Country (2026-2031)

7 Asia-Pacific Semaglutide Intermediate P29 by Region

  • 7.1 Asia-Pacific Semaglutide Intermediate P29 Historic Market Size by Region
    • 7.1.1 Asia-Pacific Semaglutide Intermediate P29 Market Size Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031
    • 7.1.2 Asia-Pacific Semaglutide Intermediate P29 Sales in Volume by Region (2020-2025)
    • 7.1.3 Asia-Pacific Semaglutide Intermediate P29 Sales in Value by Region (2020-2025)
  • 7.2 Asia-Pacific Semaglutide Intermediate P29 Forecasted Market Size by Region
    • 7.2.1 Asia-Pacific Semaglutide Intermediate P29 Sales in Volume by Region (2026-2031)
    • 7.2.2 Asia-Pacific Semaglutide Intermediate P29 Sales in Value by Region (2026-2031)

8 Company Profiles

  • 8.1 Zhuhai Gene-Biocon Biological Technology Co., Ltd.
    • 8.1.1 Zhuhai Gene-Biocon Biological Technology Co., Ltd. Company Information
    • 8.1.2 Zhuhai Gene-Biocon Biological Technology Co., Ltd. Introduction and Business Overview
    • 8.1.3 Zhuhai Gene-Biocon Biological Technology Co., Ltd. Semaglutide Intermediate P29 Sales, Revenue and Gross Margin (2020-2025)
    • 8.1.4 Zhuhai Gene-Biocon Biological Technology Co., Ltd. Semaglutide Intermediate P29 Products Offered
  • 8.2 Vazyme International LLC
    • 8.2.1 Vazyme International LLC Company Information
    • 8.2.2 Vazyme International LLC Introduction and Business Overview
    • 8.2.3 Vazyme International LLC Semaglutide Intermediate P29 Sales, Revenue and Gross Margin (2020-2025)
    • 8.2.4 Vazyme International LLC Semaglutide Intermediate P29 Products Offered
  • 8.3 PEG-BIO Biopharm Co
    • 8.3.1 PEG-BIO Biopharm Co Company Information
    • 8.3.2 PEG-BIO Biopharm Co Introduction and Business Overview
    • 8.3.3 PEG-BIO Biopharm Co Semaglutide Intermediate P29 Sales, Revenue and Gross Margin (2020-2025)
    • 8.3.4 PEG-BIO Biopharm Co Semaglutide Intermediate P29 Products Offered
    • 8.3.5 PEG-BIO Biopharm Co Recent Development
  • 8.4 Asymchem Inc.
    • 8.4.1 Asymchem Inc. Company Information
    • 8.4.2 Asymchem Inc. Introduction and Business Overview
    • 8.4.3 Asymchem Inc. Semaglutide Intermediate P29 Sales, Revenue and Gross Margin (2020-2025)
    • 8.4.4 Asymchem Inc. Semaglutide Intermediate P29 Products Offered
  • 8.5 Nanjing Hanxin Pharmaceutical Technology Co.,Ltd.
    • 8.5.1 Nanjing Hanxin Pharmaceutical Technology Co.,Ltd. Company Information
    • 8.5.2 Nanjing Hanxin Pharmaceutical Technology Co.,Ltd. Introduction and Business Overview
    • 8.5.3 Nanjing Hanxin Pharmaceutical Technology Co.,Ltd. Semaglutide Intermediate P29 Sales, Revenue and Gross Margin (2020-2025)
    • 8.5.4 Nanjing Hanxin Pharmaceutical Technology Co.,Ltd. Semaglutide Intermediate P29 Products Offered
  • 8.6 Nanjing Abydos Pharma Co.,Ltd.
    • 8.6.1 Nanjing Abydos Pharma Co.,Ltd. Company Information
    • 8.6.2 Nanjing Abydos Pharma Co.,Ltd. Introduction and Business Overview
    • 8.6.3 Nanjing Abydos Pharma Co.,Ltd. Semaglutide Intermediate P29 Sales, Revenue and Gross Margin (2020-2025)
    • 8.6.4 Nanjing Abydos Pharma Co.,Ltd. Semaglutide Intermediate P29 Products Offered
  • 8.7 Changzhou Xuanming Pharmaceutical Technology Co., Ltd.
    • 8.7.1 Changzhou Xuanming Pharmaceutical Technology Co., Ltd. Company Information
    • 8.7.2 Changzhou Xuanming Pharmaceutical Technology Co., Ltd. Introduction and Business Overview
    • 8.7.3 Changzhou Xuanming Pharmaceutical Technology Co., Ltd. Semaglutide Intermediate P29 Sales, Revenue and Gross Margin (2020-2025)
    • 8.7.4 Changzhou Xuanming Pharmaceutical Technology Co., Ltd. Semaglutide Intermediate P29 Products Offered

9 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

  • 9.1 Semaglutide Intermediate P29 Key Raw Materials
    • 9.1.1 Key Raw Materials
    • 9.1.2 Raw Materials Key Suppliers
  • 9.2 Manufacturing Cost Structure
    • 9.2.1 Raw Materials
    • 9.2.2 Labor Cost
    • 9.2.3 Manufacturing Expenses
  • 9.3 Semaglutide Intermediate P29 Production Process
  • 9.4 Semaglutide Intermediate P29 Market Dynamics
    • 9.4.1 Semaglutide Intermediate P29 Industry Trends
    • 9.4.2 Semaglutide Intermediate P29 Market Drivers
    • 9.4.3 Semaglutide Intermediate P29 Market Challenges
    • 9.4.4 Semaglutide Intermediate P29 Market Restraints

10 Semaglutide Intermediate P29 Downstream Customers

11 Research Findings and Conclusion

12 Appendix

  • 12.1 Research Methodology
    • 12.1.1 Methodology/Research Approach
    • 12.1.2 Data Source
  • 12.2 Author Details
  • 12.3 Disclaimer 99